Roberts, Glore & Co’s Intuitive Surgical ISRG Stock Holding History

Roberts, Glore & Co’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-636	Closed	-$229K	–	207
2021 Q4	$229K	Buy	+636	New	+$219K	0.06%	187

Other funds holding ISRG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Roberts, Glore & Co's ISRG Position: Q1 2022 in Review

Roberts, Glore & Co sold out of Intuitive Surgical (ISRG) in Q1 2022, closing a stake of 636 shares — an estimated $229K sold.

Roberts, Glore & Co first reported a position in ISRG in Q4 2021 and held it in 1 quarter. The position peaked at $229K in Q4 2021. 1,468 funds tracked by Wall St. Rank hold ISRG as of Q1 2022.

Roberts, Glore & Co reported no remaining Intuitive Surgical position as of Q1 2022 after selling out during the quarter.
Roberts, Glore & Co sold 636 Intuitive Surgical shares in Q1 2022, an estimated $229K.
Roberts, Glore & Co first reported a position in Intuitive Surgical in Q4 2021 and held it in 1 quarter.
Roberts, Glore & Co's Intuitive Surgical position peaked at $229K in Q4 2021.
1,468 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2022.

Based on Roberts, Glore & Co's 13F filing for Q1 2022, filed 2 May 2022.